- Home
- VIRT vs KYMR Comparison
VIRT vs KYMR Comparison
Compare VIRT & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRT
- KYMR
- Stock Information
- Founded
- VIRT 2008
- KYMR 2015
- Country
- VIRT United States
- KYMR United States
- Employees
- VIRT N/A
- KYMR N/A
- Industry
- VIRT Investment Bankers/Brokers/Service
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- VIRT Finance
- KYMR Health Care
- Exchange
- VIRT Nasdaq
- KYMR Nasdaq
- Market Cap
- VIRT 3.5B
- KYMR 3.1B
- IPO Year
- VIRT 2015
- KYMR 2020
- Fundamental
- Price
- VIRT $41.84
- KYMR $41.14
- Analyst Decision
- VIRT Hold
- KYMR Strong Buy
- Analyst Count
- VIRT 8
- KYMR 15
- Target Price
- VIRT $39.75
- KYMR $58.53
- AVG Volume (30 Days)
- VIRT 821.4K
- KYMR 623.0K
- Earning Date
- VIRT 10-23-2025
- KYMR 08-11-2025
- Dividend Yield
- VIRT 2.29%
- KYMR N/A
- EPS Growth
- VIRT 122.21
- KYMR N/A
- EPS
- VIRT 4.40
- KYMR N/A
- Revenue
- VIRT $2,617,631,000.00
- KYMR $44,711,000.00
- Revenue This Year
- VIRT N/A
- KYMR $58.45
- Revenue Next Year
- VIRT N/A
- KYMR N/A
- P/E Ratio
- VIRT $9.54
- KYMR N/A
- Revenue Growth
- VIRT 42.88
- KYMR N/A
- 52 Week Low
- VIRT $29.82
- KYMR $19.45
- 52 Week High
- VIRT $45.77
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- VIRT 44.00
- KYMR 46.66
- Support Level
- VIRT $40.71
- KYMR $41.20
- Resistance Level
- VIRT $43.62
- KYMR $44.27
- Average True Range (ATR)
- VIRT 0.89
- KYMR 1.85
- MACD
- VIRT 0.08
- KYMR 0.06
- Stochastic Oscillator
- VIRT 38.83
- KYMR 60.32
About VIRT Virtu Financial Inc.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.